Cargando…
Prognostic value of Bcl-2 expression in patients with non-small-cell lung cancer: a meta-analysis and systemic review
OBJECTIVE: B-cell-lymphoma-2 (Bcl-2) is a proto-oncogene that plays an important role in the regulation of apoptosis and cell survival. However, there are much conflicting data in the literature concerning the association between Bcl-2 and prognosis in non-small-cell lung cancer (NSCLC). There is li...
Autores principales: | Zhang, Jie, Wang, Shengfei, Wang, Lei, Wang, Rui, Chen, Sufeng, Pan, Bin, Sun, Yihua, Chen, Haiquan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4655977/ https://www.ncbi.nlm.nih.gov/pubmed/26604794 http://dx.doi.org/10.2147/OTT.S89275 |
Ejemplares similares
-
The pemetrexed-containing treatments in the non-small cell lung cancer, is -/low thymidylate synthase expression better than +/high thymidylate synthase expression: a meta-analysis
por: Wang, Lei, et al.
Publicado: (2014) -
The prognostic and predictive value of solid subtype in invasive lung adenocarcinoma
por: Zhang, Yang, et al.
Publicado: (2014) -
Lymph node metastasis according to primary tumor location in T1 and T2 stage non‐small cell lung cancer patients
por: Xiong, Jian, et al.
Publicado: (2016) -
Clinical analysis of sixty‐four patients with T1aN2M0 stage non‐small cell lung cancer who had undergone resection
por: Xiong, Jian, et al.
Publicado: (2015) -
Primary concomitant EGFR T790M mutation predicted worse prognosis in non-small cell lung cancer patients
por: Li, Hang, et al.
Publicado: (2014)